GGrantIndex
← Leaderboards

John J Mieyal

Case Western Reserve University

Google Scholar ↗PubMed ↗ORCID ↗
$4,307,881
Attributed
$5,288,330
Total exposure
5
Grants
4
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $442.2K · FY2005–23
$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23

Funding mix

By agency

NIH$5,288,330 · 4
VA$0 · 1

By mechanism

T32$3,542,160 · 1
R01$683,107 · 1
P01$629,170 · 1
R21$433,893 · 1
I01$0 · 1

Top collaborators

Most similar at Case Western Reserve University

Same institution · by research overlap

Others in their field

Top investigators on “Molecular”

Research focus

MolecularPre-DoctoralTraining ProgramsOxidative StressMitochondriaAgingThioredoxinCell SurvivalGlutaredoxinCellsAffectElderlySulfhydryl CompoundsOxidation-ReductionApoptosisAntioxidantsEnzyme ActivityMyocardial Ischemia /HypoxiaGlutathioneEquilibriumEnzymesDopamineDopaminergic NeuronDeterioration

Grant awards (32)

Pre-doctoral Training Program in Molecular Therapeutics$202,378
T32 · FY2023 · GM
Pre-doctoral Training Program in Molecular Therapeutics$312,217
T32 · FY2022 · GM
Pre-doctoral Training Program in Molecular Therapeutics$292,577
T32 · FY2021 · GM
Pre-doctoral Training Program in Molecular Therapeutics$289,234
T32 · FY2020 · GM
Pre-doctoral Training Program in Molecular Therapeutics$285,968
T32 · FY2019 · GM
Predoctoral Training in Molecular Therapeutics$227,354
T32 · FY2018 · GM · contact PI
Predoctoral Training in Molecular Therapeutics$186,446
T32 · FY2017 · GM · contact PI
Predoctoral Training in Molecular Therapeutics$184,424
T32 · FY2016 · GM · contact PI
Predoctoral Training in Molecular Therapeutics$182,454
T32 · FY2015 · GM · contact PI
Glutaredoxin, a Critical Regulator of Parkinson Disease Pathogenesis$196,143
R21 · FY2014 · NS
Predoctoral Training in Molecular Therapeutics$180,536
T32 · FY2014 · GM · contact PI
Glutaredoxin, a Critical Regulator of Parkinson Disease Pathogenesis$237,750
R21 · FY2013 · NS
Predoctoral Training Program in Molecular Therapeutics$205,911
T32 · FY2012 · GM · contact PI
Enzymatic Regulation of S-Glutathionylation : Role in Apoptosis and Disease$0
I01 · FY2012 · VA · contact PI
Predoctoral Training Program in Molecular Therapeutics$214,715
T32 · FY2011 · GM · contact PI
Enzymatic Regulation of S-Glutathionylation : Role in Apoptosis and Disease$0
I01 · FY2011 · VA · contact PI
Enzymatic Regulation of S-Glutathionylation : Role in Apoptosis and Disease$0
I01 · FY2011 · VA · contact PI
Predoctoral Training Program in Molecular Therapeutics$127,468
T32 · FY2010 · GM · contact PI
Predoctoral Training Program in Molecular Therapeutics$253,614
T32 · FY2009 · GM · contact PI
Predoctoral Training Program in Molecular Therapeutics$126,807
T32 · FY2009 · GM · contact PI
SULFHYDRYL STATUS IN THE AGING HEART: ROLE OF GLUTAREDOXIN$196,619
P01 · FY2008 · AG · contact PI
Predoctoral Training Program in Molecular Therapeutics$84,098
T32 · FY2008 · GM · contact PI
SULFHYDRYL STATUS IN THE AGING HEART: ROLE OF GLUTAREDOXIN$194,685
P01 · FY2007 · AG · contact PI
Sulfhydryl Status in Aging Heart: Role of Glutaredoxin$224,107
R01 · FY2006 · AG · contact PI
SULFHYDRYL STATUS IN THE AGING HEART: ROLE OF GLUTAREDOXIN$27,583
P01 · FY2006 · AG · contact PI
Sulfhydryl Status in Aging Heart: Role of Glutaredoxin$229,500
R01 · FY2005 · AG
PREDOCTORAL TRAINING PROGRAM IN MOLECULAR THERAPEUTICS$185,959
T32 · FY2005 · GM
SULFHYDRYL STATUS IN THE AGING HEART: ROLE OF GLUTAREDOXIN$26,778
P01 · FY2005 · AG
Sulfhydryl Status in Aging Heart: Role of Glutaredoxin$229,500
R01 · FY2004 · AG
SULFHYDRYL STATUS IN THE AGING HEART: ROLE OF GLUTAREDOXIN$25,999
P01 · FY2004 · AG
HEART MITOCHONDRIAL THIOL STATUS--ROLE IN AGING DEFECTS$0
P01 · FY2001 · AG
HEART MITOCHONDRIAL THIOL STATUS--ROLE IN AGING DEFECTS$157,506
P01 · FY2000 · AG